Elecsys PRO-C3

From the manufacturer

Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.

• Intended use Elecsys PRO-C3 is an in vitro quantitative immunoassay for the determination of N-terminal pro-peptide of type III collagen (PRO-C3) in human serum and plasma.The assay is intended to be used as part of the ADAPT algorithm (patient age, diabetes status, PRO-C3, platelet count) to assess the severity of hepatic fibrosis in patients showing evidence or signs of metabolic…

  Roche DiagnosticsApplication AreaManufacturer Page2026-10-06

• The ADAPT result must be interpreted in conjunction with other methods and in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for u

  Roche DiagnosticsCategory L1Manufacturer Page2026-10-06